Evoke Pharma (EVOK) Revenue & Revenue Breakdown
Evoke Pharma Revenue Highlights
Latest Revenue (Y)
$10.25T
Latest Revenue (Q)
$2.65M
Main Segment (Y)
Pharmaceutical Products
Evoke Pharma Revenue by Period
Evoke Pharma Revenue by Year
Date | Revenue | Change |
---|---|---|
2024-12-31 | $10.25T | 197840992.69% |
2023-12-31 | $5.18M | 106.51% |
2022-12-31 | $2.51M | 55.04% |
2021-12-31 | $1.62M | 6929.00% |
2020-12-31 | $23.02K | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2013-12-31 | - | 100.00% |
2012-12-31 | - | 100.00% |
2011-12-31 | - | - |
Evoke Pharma generated $10.25T in revenue during NA 2024, up 197840992.69% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Evoke Pharma Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $2.65M | 4.03% |
2024-06-30 | $2.55M | 47.01% |
2024-03-31 | $1.74M | 3.55% |
2023-12-31 | $1.68M | 7.24% |
2023-09-30 | $1.56M | 38.14% |
2023-06-30 | $1.13M | 39.60% |
2023-03-31 | $810.41K | 1.76% |
2022-12-31 | $796.37K | -4.29% |
2022-09-30 | $832.10K | 80.19% |
2022-06-30 | $461.80K | 10.38% |
2022-03-31 | $418.38K | 16.03% |
2021-12-31 | $360.57K | -61.25% |
2021-09-30 | $930.45K | 293.20% |
2021-06-30 | $236.63K | 161.70% |
2021-03-31 | $90.42K | 292.79% |
2020-12-31 | $23.02K | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2016-09-30 | - | 100.00% |
2016-06-30 | - | 100.00% |
2016-03-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2015-09-30 | - | 100.00% |
2015-06-30 | - | 100.00% |
2015-03-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2014-09-30 | - | 100.00% |
2014-06-30 | - | 100.00% |
2014-03-31 | - | 100.00% |
2013-12-31 | - | 100.00% |
2013-09-30 | - | 100.00% |
2013-06-30 | - | 100.00% |
2013-03-31 | - | 100.00% |
2012-12-31 | - | 100.00% |
2012-09-30 | - | 100.00% |
2012-06-30 | - | 100.00% |
2012-03-31 | - | - |
Evoke Pharma generated $2.65M in revenue during Q3 2024, up 4.03% compared to the previous quarter, and up 234.60% compared to the same period a year ago.
Evoke Pharma Revenue Breakdown
Evoke Pharma Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 24 |
---|---|
Pharmaceutical Products | $10.25M |
Latest
Evoke Pharma's latest annual revenue breakdown by segment (product or service), as of Dec 24: Pharmaceutical Products (100.00%).
Evoke Pharma Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
EVOK | Evoke Pharma | $10.25T | $2.65M |
PTPI | Petros Pharmaceuticals | $5.11B | $1.42M |
PROC | Procaps Group | $409.92M | $118.41M |
AVDL | Avadel Pharmaceuticals | $169.12M | $50.02M |
AQST | Aquestive Therapeutics | $57.56M | $13.54M |
DERM | Journey Medical | $56.13M | $14.86M |
CPIX | Cumberland Pharmaceuticals | $37.87M | $9.09M |
BFRI | Biofrontera | $37.30M | $7.83M |
AKAN | Akanda | $2.16M | $762.61K |
SHPH | Shuttle Pharmaceuticals | - | - |
PRFX | PainReform | - | - |
IXHL | Incannex Healthcare | - | - |
RGC | Regencell Bioscience | - | - |